RetractedTrialMedical oncology (Northwood, London, England)2014

A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients.

Jun Yao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.